Sickle Cell Disease Trial, Recruiting (NCT05383911)

Sickle Cell Disease Trial, Recruiting NCT05383911 Sponsor: Nemours Children's Clinic Condition: Sickle Cell Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05383911 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sickle Cell Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Patients aged 15 to 25 years who have been diagnosed with Sickle Cell Disease (SCD) and are receiving care at Nemours, along with their caregivers
Patients whose SCD healthcare provider has determined they are candidates to start one or more treatments that can change the course of the disease
Healthcare providers at Nemours who treat patients with SCD
All participants must be fluent in English

Who may not be able to join:

Patients or caregivers who have already taken part in usability testing of this intervention
Patients who have a history of seizures
Patients whose health condition or thinking and communication abilities would make it too difficult to complete interviews
Patients under 18 years of age who do not have a legal guardian available to give consent on their behalf
Healthcare providers who are still in training

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 302-723-9331

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05383911

Sponsor: Nemours Children's Clinic

Phase: Not Applicable

Status: Recruiting

Condition: Sickle Cell Disease

Trial contact: 302-723-9331

More information: https://clinicaltrials.gov/study/NCT05383911

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Patients aged 15 to 25 years who have been diagnosed with Sickle Cell Disease (SCD) and are receiving care at Nemours, along with their caregivers
Patients whose SCD healthcare provider has determined they are candidates to start one or more treatments that can change the course of the disease
Healthcare providers at Nemours who treat patients with SCD
All participants must be fluent in English

Who may not be able to join:

Patients or caregivers who have already taken part in usability testing of this intervention
Patients who have a history of seizures
Patients whose health condition or thinking and communication abilities would make it too difficult to complete interviews
Patients under 18 years of age who do not have a legal guardian available to give consent on their behalf
Healthcare providers who are still in training

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nemours Children's Clinic

Registry

ClinicalTrials.gov

Start date

26 November 2024

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Acceptability of Intervention Measure (AIM); Patient/Caregiver Satisfaction Questionnaire; Feasibility of Intervention Measure (FIM); Participant Recruitment Rate; Shared Decision Making Questionnaire (SDM-Q-9); Disease-Modifying Therapy Knowledge Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov